Exploration of Targeted Anti-tumor Therapy

Open Access Commentary

A decade of CD4+ chimeric antigen receptor T-cell evolution in two chronic lymphocytic leukemia patients: were chronic lymphocytic leukemia cells present?

Dimitrios Bouzianas, Stella Bouziana

Published: October 31, 2023 Explor Target Antitumor Ther. 2023;4:1128–1135

DOI: https://doi.org/10.37349/etat.2023.00186

This article belongs to the special issue Novel Strategies and Targets for Immunotherapy of Cancer

Full Text PDF

2155 22 2

Open Access Perspective

Cholesterol esterification and p53-mediated tumor suppression

Youjun Li ... Edward V. Prochownik

Published: October 31, 2023 Explor Target Antitumor Ther. 2023;4:1122–1127

DOI: https://doi.org/10.37349/etat.2023.00185

This article belongs to the special issue Therapeutic Targeting of the Tumor Microenvironment

Full Text PDF

2231 31 1

Open Access Original Article

Acryl-3,5-bis(2,4-difluorobenzylidene)-4-piperidone targeting cellular JUN proto-oncogene, AP-1 transcription factor subunit inhibits head and neck squamous cell carcinoma progression

Levi Arnold ... Sufi Mary Thomas

Published: October 31, 2023 Explor Target Antitumor Ther. 2023;4:1104–1121

DOI: https://doi.org/10.37349/etat.2023.00184

This article belongs to the special issue Therapeutic Targeting of the Tumor Microenvironment

Full Text PDF

2529 91 1

Open Access Systematic Review

Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology

Veronica Agostinelli ... Rossana Berardi

Published: October 30, 2023 Explor Target Antitumor Ther. 2023;4:1095–1103

DOI: https://doi.org/10.37349/etat.2023.00183

This article belongs to the special issue COVID-19 and Cancer

Full Text PDF

1640 13 0

Open Access Review

Coronavirus disease 2019 and lung cancer: where are we?

Abrahams Ocanto ... Felipe Couñago

Published: October 30, 2023 Explor Target Antitumor Ther. 2023;4:1082–1094

DOI: https://doi.org/10.37349/etat.2023.00182

This article belongs to the special issue COVID-19 and Cancer

Full Text PDF

2017 17 1

Open Access Review

Overcoming phenotypic switching: targeting protein-protein interactions in cancer

Christos Ladias ... Nikolaos A. Papanikolaou

Published: October 30, 2023 Explor Target Antitumor Ther. 2023;4:1071–1081

DOI: https://doi.org/10.37349/etat.2023.00181

This article belongs to the special issue Off-label drugs and -omics data in cancer treatment

Full Text PDF

2230 28 1

Open Access Original Article

Effect of vitamin D supplementation on inflammatory markers and total antioxidant capacity in breast cancer women using a machine learning technique

Marzieh Tahmasebi ... Amir Jamshidnezhad

Published: October 30, 2023 Explor Target Antitumor Ther. 2023;4:1059–1070

DOI: https://doi.org/10.37349/etat.2023.00180

Full Text PDF

1917 26 1

Open Access Systematic Review

Effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review

Afrooz Mazidimoradi ... Hamid Salehiniya

Published: October 26, 2023 Explor Target Antitumor Ther. 2023;4:1039–1058

DOI: https://doi.org/10.37349/etat.2023.00179

This article belongs to the special issue COVID-19 and Cancer

Full Text PDF

1665 16 2

Open Access Review

Integration of signaling pathway and bromodomain and extra-terminal domain inhibition for the treatment of mutant Kirsten rat sarcoma viral oncogene homolog cancer

Gerhard Hamilton ... Barbara Rath

Published: October 26, 2023 Explor Target Antitumor Ther. 2023;4:1027–1038

DOI: https://doi.org/10.37349/etat.2023.00178

This article belongs to the special issue Integrated Approaches for Non-Small-Cell Lung Cancer

Full Text PDF

2491 23 2

Open Access Review

A review on in silico virtual screening methods in COVID-19 using anticancer drugs and other natural/chemical inhibitors

Babak Sokouti

Published: October 26, 2023 Explor Target Antitumor Ther. 2023;4:994–1026

DOI: https://doi.org/10.37349/etat.2023.00177

Full Text PDF

2477 40 1

Open Access Review

Melatonin, BAG-1 and cortisol circadian interactions in tumor pathogenesis and patterned immune responses

George Anderson

Published: October 25, 2023 Explor Target Antitumor Ther. 2023;4:962–993

DOI: https://doi.org/10.37349/etat.2023.00176

This article belongs to the special issue Novel Insights into Immunotherapy Targeting Tumor Microenvironment in Cancer

Full Text PDF

3133 36 11

Open Access Review

Biomarkers in renal cell carcinoma and their targeted therapies: a review

Shruti Gupta, Shamsher Singh Kanwar

Published: October 25, 2023 Explor Target Antitumor Ther. 2023;4:941–961

DOI: https://doi.org/10.37349/etat.2023.00175

This article belongs to the special issue Biomarkers for Personalized and Precise Cancer Diagnosis and Treatment

Full Text PDF

2907 35 5

Open Access Systematic Review

Current role of artificial intelligence in head and neck cancer surgery: a systematic review of literature

Antonella Loperfido ... Gianluca Bellocchi

Published: October 24, 2023 Explor Target Antitumor Ther. 2023;4:933–940

DOI: https://doi.org/10.37349/etat.2023.00174

This article belongs to the special issue Artificial Intelligence for Precision Oncology

Full Text PDF

2885 47 10

Open Access Review

Molecular interaction of metastasis suppressor genes and tumor microenvironment in breast cancer

Sathammai Sathappa Supuramanian ... Sitaram Harihar

Published: October 11, 2023 Explor Target Antitumor Ther. 2023;4:912–932

DOI: https://doi.org/10.37349/etat.2023.00173

This article belongs to the special issue Therapeutic Targeting of the Tumor Microenvironment

Full Text PDF

2180 35 1

Open Access Original Article

Exploring the implications of modified advanced lung cancer inflammation index on outcomes in patients with advanced non-small cell lung cancer

Abhishek Mahajan ... Kumar Prabhash

Published: October 11, 2023 Explor Target Antitumor Ther. 2023;4:896–911

DOI: https://doi.org/10.37349/etat.2023.00172

This article belongs to the special issue Biomarkers for Personalized and Precise Cancer Diagnosis and Treatment

Full Text PDF

1956 29 3

Open Access Review

Understanding the feasibility of chemotherapeutic and immunotherapeutic targets against non-small cell lung cancers: an update of resistant responses and recent combinatorial therapies

Parth Malik ... Tapan Kumar Mukherjee

Published: October 10, 2023 Explor Target Antitumor Ther. 2023;4:850–895

DOI: https://doi.org/10.37349/etat.2023.00171

This article belongs to the special issue Integrated Approaches for Non-Small-Cell Lung Cancer

Full Text PDF

2753 46 10

Open Access Review

AGEs and RAGE: metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers

Gowri Palanissami, Solomon F.D. Paul

Published: September 28, 2023 Explor Target Antitumor Ther. 2023;4:812–849

DOI: https://doi.org/10.37349/etat.2023.00170

This article belongs to the special issue Biomarkers for Personalized and Precise Cancer Diagnosis and Treatment

Full Text PDF

5070 70 17

Open Access Review

Malignant tumors of the external auditory canal: diagnosis, treatment, genetic landscape, biomarkers, and clinical outcome

Pinelopi Samara ... Ioannis Athanasopoulos

Published: September 21, 2023 Explor Target Antitumor Ther. 2023;4:801–811

DOI: https://doi.org/10.37349/etat.2023.00169

This article belongs to the special issue Biomarkers for Personalized and Precise Cancer Diagnosis and Treatment

Full Text PDF

3557 59 6

Open Access Original Article

A single experience in the conduction of clinical trial during COronaVIrusDisease-2019 pandemic

Zelmira Ballatore ... Rossana Berardi

Published: September 07, 2023 Explor Target Antitumor Ther. 2023;4:793–800

DOI: https://doi.org/10.37349/etat.2023.00168

This article belongs to the special issue COVID-19 and Cancer

Full Text PDF

1719 21 0